Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Identification of Tumor Antigens and Immune Subtypes of Glioblastoma for mRNA Vaccine Development.

Frontiers in immunology - 1 Jan 2022

Lin Han, Wang Kun, Xiong Yuxin, Zhou Liting, Yang Yong, Chen Shanwei, Xu Peihong, Zhou Yujun, Mao Rui, Lv Guangzhao, Wang Peng, Zhou Dong

Abstract excerpt

The use of vaccines for cancer therapy is a promising immunotherapeutic strategy that has been shown to be effective against various cancers. Vaccines directly target tumors but their efficacy against glioblastoma multiforme (GBM) remains unclear. Immunotyping that classifies tumor samples is considered to be a biomarker for immunotherapy. This study aimed to identify potential GBM antigens suitable for vaccine...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antigens, Neoplasm
Share to Brain Neoplasms

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Cancer Vaccines

Share to Databases, Genetic

Share to Glioblastoma

Share to Immunophenotyping

Share to Tumor Microenvironment

Share to Vaccines, Synthetic

Source

Open in PubMed Open full text

Identifiers

PMID: 35185876
DOI: 10.3389/fimmu.2022.773264
PMCID: PMC8847306

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Identification of Tumor Antigens and Immune Subtypes of Glioblastoma for mRNA Vaccine Development.PMID 35185876Read ↗

Tumor antigens and immune subtypes of glioblastoma: the fundamentals of mRNA vaccine and individualized immunotherapy developmentSemantic proximity Read ↗

Recognition of Tumor-Associated Antigens and Immune Subtypes in Glioma for mRNA Vaccine Development.Semantic proximity Read ↗

Dissecting Tumor Antigens and Immune Subtypes of Glioma to Develop mRNA Vaccine.Semantic proximity Read ↗

Identification of tumor antigens and immune subtypes in lower grade gliomas for mRNA vaccine developmentSemantic proximity Read ↗

Genomics and proteomics to determine novel molecular subtypes and predict the response to immunotherapy and the effect of bevacizumab in glioblastoma.Semantic proximity Read ↗

Identification of tumor-associated antigens and immune subtypes of lower-grade glioma and glioblastoma for mRNA vaccine developmentSemantic proximity Read ↗

Identification of an Immune-Related Prognostic Signature for Glioblastoma by Comprehensive Bioinformatics and Experimental AnalysesSemantic proximity Read ↗

Molecular subtyping of glioblastoma based on immune-related genes for prognosisSemantic proximity Read ↗

Establishment and validation of an immune-based prognostic score model in glioblastoma.Semantic proximity Read ↗

Identification of Immune-Related lncRNA Prognostic Signature and Molecular Subtypes for GlioblastomaSemantic proximity Read ↗

Tumor antigens and immunogenic cell death subtypes guided mRNA vaccine development for lower-grade gliomasSemantic proximity Read ↗

Investigation of Genetic Determinants of Glioma Immune Phenotype by Integrative Immunogenomic Scale AnalysisSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.